CTA 056 structure
|
Common Name | CTA 056 | ||
---|---|---|---|---|
CAS Number | 1265822-30-7 | Molecular Weight | 554.68400 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C35H34N6O | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CTA 056CTA056 is an ITK (IL-2-inducible T-cell kinase) inhibitor with an IC50 of 0.1 μM. CTA056 selectively targets malignant T cells and modulates oncomirs. CTA056 induces apoptosis and is a potential therapeutic agent for the treatment of T-cell leukemia and lymphoma[1]. |
Name | 7-benzyl-1-(3-(piperidin-1-yl)propyl)-2-(4-(pyridin-4-yl)phenyl)-1H-imidazo[4,5-g]quinoxalin-6(5H)-one |
---|---|
Synonym | More Synonyms |
Description | CTA056 is an ITK (IL-2-inducible T-cell kinase) inhibitor with an IC50 of 0.1 μM. CTA056 selectively targets malignant T cells and modulates oncomirs. CTA056 induces apoptosis and is a potential therapeutic agent for the treatment of T-cell leukemia and lymphoma[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C35H34N6O |
---|---|
Molecular Weight | 554.68400 |
Exact Mass | 554.27900 |
PSA | 79.70000 |
LogP | 6.40650 |
cta-056 |
cta056 |